This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Ellouz, F., Adam, A., Ciorbaru, R. and Lederer, E. 1974. Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives. Biochem. Biophys. Res. Comm. 59: 1317.
Allison, A.C., Byars, N.E. and Waters, R.V. 1986. Immunologic adjuvants: efficacy and safety considerations, pp. 91–103 In: Advances in Carriers and Adjuvants for Veterinary Biologies. R. M. Nervig, P. M. Gough, M. L. Kaeberle, and C. A. Whetstone (eds.), Iowa State University Press, Ames, Iowa.
Geczy, A.F., Alexander, K., Bashir, H.V., Edmonds, J.P., Upfold, L. and Sullivan, J. 1983. HLA-B27, Klebsiella and ankylosing spondylitis: biological and chemical studies. Immunol. Rev. 70: 23.
Allison, A.C. and Byars, N.E. 1986. An adjuvant formulation that selectively elicits the formation of antibodies of protective isotypes and of cell-mediated immunity. J. Immunol. Methods 95: 157.
Schmolka, I.R. 1977. A review of block polymer surfactants. J. Am. Oil Chem. Soc. 54: 110.
Klaus, G.G., Humphrey, J.H., Kunkl, A. and Dongworth, D.W. 1980. The follicular dendritic cell: its role in antigen presentation in the generation of immunological memory. Immunol. Rev. 53: 3.
Ron, Y. and Sprent, J. 1987. T cell priming in vivo: a major role for B cells in presenting antigen to T cells in lymph nodes. J. Immunol. 138: 2848.
Braemer, A.C., Allison, A.C., Byars, N.E., Cutting, J.A., Dietrich, D., McRoberts, M. and Renneke, G. 1987. Proceedings of the XIIIth Symposium of the International Association for Comparative Research on Leukemia and Related Diseases, Jerusalem (in press).
Marx, P.A., Pedersen, N.C., Lerche, N.W., Osborn, K.G., Lowenstine, L.J., Lockner, A.A., Maul, D.H., Kwang, H.-S., Kluge, J.D., Zaiss, C.P., Sharpe, V., Spunner, A.P., Allison, A.C. and Gardner, M.B. 1986. Prevention of simian acquired immune deficiency syndrome with a formalin-inactivated type D retrovirus vaccine. J. Virol. 60: 431.
Letvin, N.L., Mutthiah, D., King, N.W., Kiotaki, M., Chalifaux, L.V., Schegal, P.K., Desrosiers, R.C., Arthur, L.O. and Allison, A.C. 1987. AIDS-like disease in macaque monkeys induced by SIV: a vaccine trial. Vaccines 87, Cold Spring Harbor Press, NY.
Berman, P.W., Gregory, T., Crase, P. and Lasky, L.A. 1985. Protection from genital herpes simplex type 2 infection by vaccination with cloned glycoprotein D. Science 227: 1490.
Bringman, T.S., Lindquist, P.B. and Derynck, R. 1987. Different transforming growth factor-alpha species are derived from a glycosylated and palmitoylated transmembrane precursor. Cell 48: 429.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Allison, A., Byars, N. Vaccine Technology: Adjuvants for Increased Efficacy. Nat Biotechnol 5, 1041–1045 (1987). https://doi.org/10.1038/nbt1087-1041
Issue Date:
DOI: https://doi.org/10.1038/nbt1087-1041